Available online on 15.03.2026 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2026 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article  Review Article

Unveiling the Notable Consequences in the Management of Anxiety Disorder

Vandana Gupta *1, and Noopur Srivastava 2

Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Naini, Prayagraj- 211007, Uttar Pradesh, INDIA

The Oxford College of Pharmacy, Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka, 560068, INDIA

Article Info:

_______________________________________________ Article History:

Received 26 Dec 2025  

Reviewed 03 Feb 2026  

Accepted 27 Feb 2026  

Published 15 March 2026  

_______________________________________________

Cite this article as: 

Gupta V, Srivastava N, Unveiling the Notable Consequences in the Management of Anxiety Disorder, Journal of Drug Delivery and Therapeutics. 2026; 16(3):304-320  DOI: http://dx.doi.org/10.22270/jddt.v16i3.7631                                                       _______________________________________________

For Correspondence:  

Vandana Gupta, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Naini, Prayagraj- 211007, Uttar Pradesh, INDIA;

Abstract

_______________________________________________________________________________________________________________

Anxiety disorders, encompassing generalized anxiety disorder, social anxiety, panic disorder, and specific phobias, are pervasive mental health conditions associated with significant distress and functional impairment. A comprehensive search was conducted from July 2024 to December 2025 across PubMed, Scopus, and Embase from inception to the present. According to the document on metabolomic markers in disorders of anxiety, these disorders arise from a complex interaction of genetic, neurobiological, and psychosocial factors. Key challenges in managing anxiety disorders include accurate diagnosis and distinguishing anxiety symptoms from overlapping medical conditions such as asthma, atrial fibrillation, and hyperthyroidism. The present investigation is narrative review. It provides an informative, valuable narrative review of the history, abnormalities, and roles of neurotransmitters—norepinephrine, serotonin, dopamine, and GABA—and the involvement of brain structures such as the amygdala and limbic system, which underscore the neurobiological basis of anxiety. Current treatments concentrate on a combination of Selective serotonin reuptake Inhibitors (SSRIs), serotonin-nor-epinephrine reuptake Inhibitors (SNRIs), and benzodiazepines, alongside cognitive behavioural remedy (CBT). However, these approaches are not universally effective, and issues such as drug dependency and side effects remain critical obstacles. Emerging research in metabolomics offers potential for identifying biomarkers that could improve diagnostic accuracy and treatment personalization. Integrating metabolomic insights with traditional and complementary therapies may enhance treatment outcomes. Addressing these multifaceted challenges requires interdisciplinary collaboration to advance research and develop tailored, effective strategies for managing anxiety disorders in diverse patient populations.

Keywords: Anxiety, Anxiety disorders, Metabolomic markers, Biomarkers.

 


 
  1. Introduction

Anxiety is an involuntary neuro-physiological condition of alertness, characterized by a fight or flight response to a cognitive assessment of current or anticipated threats, whether they are real or perceived. It is linked to sensations of anxiety and manifests as a mood state that is commonly associated with luck (fig 1), encompassing a multifaceted system of cognitive, emotional, physiological, and behavioral responses related to the anticipated conditions or situations perceived as uncertain1.

The word anxiety is determined from the Latinword, “anxietas” (to choke, throttle, inconvenience, and disturbed) and envelops behavioural, full of feeling and cognitive reactions to the recognition of peril. In balance, uneasiness fortifies an expectant and versatile reaction to challenging or upsetting occasions. In overabundance, uneasiness destabilizes the person and broken state comes about. Uneasiness is considered over the top or obsessive when it emerges in the nonappearance of challenge or stretch, when it is out of extent to the challenge or push in length or seriousness, when it comes about in critical trouble, and when it comes about in mental, social, word related, organic, and other disability2, 3.

 

Figure 1: Illustrative representation of anxiety disorder

1.1 Epidemiology

Anxiety ranks among the most prevalent psychiatric disorders within the general population. Specific phobia is the most frequently encountered, exhibiting a 12-month prevalence rate of 12.1%. Following this, social anxiety disorder is the next most common, with a prevalence rate of 7.4% over the same period. Agoraphobia is the least prevalent anxiety disorder, with a 12-month prevalence rate of 2.5%. Furthermore, anxiety disorders are more commonly observed in women than in men, with an approximate ratio of 2:14.

1.2 Pathophysiology

The substantial brokers of pressure inside the top anxious machine are generality norepinephrine, serotonin, dopamine, and gamma- aminobutyric acid (GABA). The autonomic frightened device, specifically the sympathetic anxious device, mediates most of the signs and symptoms.

The amygdala performs a crucial function in tempering fear and anxiety. Individuals experiencing anxiety disorders were found to exhibit heightened amygdala responses to stress signals. The amygdala and limbic systems are interconnected with areas of the prefrontal cortex, and irregularities in prefrontal-limbic activation can be mitigated through psychological or pharmacological treatments5.

1.3 Etiology

Anxiety diseases appear to be because of commerce of the bio-psychosocial rudiments. Inheritable vulnerability interacts with situations that are disturbing or demanding to supply clinically large runs. Anxiety may be resulting from the subsequent situations6:

  1. Pharmaceutical treatments
  2. Herbal remedies, 
  3. Substance dependency, 
  4. Traumatic experiences, 
  5. Childhood events, 
  6. Panic diseases

1.4 History of anxiety

Anxiety disorders have always been a fundamental part of the human experience. Historical documents from as far back as 5,000 BC depict occurrences similar to what we currently identify as Post-Traumatic Stress Disorder (PTSD) in ancient Indian literature. However, the formal study of anxiety appears to have originated approximately 2,000 years ago in the Greco-Roman world. Prominent figures such as Hippocrates, Cicero, and Seneca documented individuals exhibiting symptoms that we currently classify as anxiety-related, including irrational fears of specific situations and persistent worry. They thought that these symptoms might be associated with physical conditions or disorders7

1.4.1 History of anxiety diagnosis

Indeed, though the Greco- Roman proponents observed anxiety signs, it took centuries for people to make a great deal of development in know- style pressure. During the 1600s, medical professionals and academics began documenting a condition they termed “melancholia”. Melancholia became a wide term that protected many specific tension and melancholy symptoms. Anxiety conditions had also been occasionally called “vapours.” Doctors didn’t absolutely apprehend that anxiety and despair have been wonderful conditions, or that there might be one of kind types of anxiety disorders.

Humanity's understanding of hysteria saw little advancement over the next two centuries. A French medical publication from the 1700s contributed to this field by introducing a term known as 'panophobia.' This condition was characterized by an intense fear experienced at night without any apparent reason. Contemporary psychologists might refer to these experiences as night terrors. The text also outlined subcategories of panophobia that align with current diagnoses such as hypochondria or generalized anxiety disorder (GAD).

Physicians had been beginning to recognise that these anxiety signs and symptoms may want to simply be grouped into different categories. The medical discipline surely was given interested in defining and diagnosing anxiety in the past due 1800s and early 1900s. It started out with the term “neurasthenia” in 1869, which included an expansive variety of excited signs and symptoms. Psychiatrists like Sigmund Freud could enlarge on that time period to upgrade the delineations of different styles of pressure indeed in addition.

The first Diagnostic and Statistical Manual of Mental Disorders (DSM) was posted in 1952. It changed into the primary time that the medical network virtually defined and wrote down steerage about the subtypes of demanding conditions. It took approximately 30 extra years to absolutely recognize these subtypes. Numerous of the anxiety judgments were acquainted with the moment and weren’t named until the DSM- III in 1980, similar as fear disease generalized anxiety complaint (GAD) compulsive-obsessive complaint (OCD), which is now considered in its very own magnificence of disorders8

1.4.2 History of anxiety treatment

While the ancients lacked advance methods for diagnosing unique anxiety disorders, their approach may seem remarkably modern. The Stoic philosophers of ancient Rome understood that symptoms of hysteria stemmed from negative or false thoughts and emotions. Consequently, they advocated for individuals to learn alternative ways to manage their internal thoughts to cope effectively. They urged people to focus on the present moment instead of fixating on the past or future. Since external events are often beyond our control, they concluded that we should instead regulate our internal responses9

1.4.2.1 20th century of remedy progress

It was not until the early 20th century that croakers and psychologists commenced to take meaningful way closer to easing anxiety for the average affected person. In the 1930s, Orval Mowrer’s 2-element theory constructed on Pavlovian conditioning, also referred to as fear conditioning, and started out the initial force toward cutting-edge publicity treatments. Once anxiety became more extensively understood, neurologists and psychologists like Sigmund Freud and John B. Watson proposed new methods of treating it.

Freud concept doctors ought to assist sufferers talk approximately their internal mind and feelings, at the same time as Mowrer notion that behaviour trade and conditioning have been the nice ways to assist. Watson’s paintings targeted greater on how you form people early in development, and the way you surely can make people worried or demanding about something. This becomes the start of current psychotherapy, and these two ideas would subsequently form the idea of cognitive behavioral therapy (CBT) 10

1.4.2.2 Strides ahead within the ‘50s

Initially referred to as, cognitive remedy, classic cognitive therapy changed into originally tested within the 1960s. The greater modern-day shape of cognitive remedy, CBT, consists of traditional cognitive therapy, exposure treatment options, as well as, behavioral, hassle-solving, and social abilities education strategies. It remains one of the most renowned strategies for treating anxiety due to the substantial evidence supporting its effectiveness in yielding optimal results. In the 60s, doctors also found out that certain forms of tablets ought to manage tension signs and symptoms. Physicians started out to move far away from treating mental illnesses at inpatient centres. Mental fitness turned into increasingly more handled at outpatient facilities. The standard approach to anxiety changed into starting to appear tons more current in terms of therapy, medication, and outpatient remedy. Psychotherapy has continued to strengthen. Researchers continue to discover new and better capsules that treat anxiety with fewer adverse effects and risk of dangers11. 

1.4.2.3 History of anxiety medication

Pharmaceuticals for anxiety treatment were not utilized until the mid-20th century, when physicians began to prescribe various medications such as:

  1. Monoamine oxidase inhibitors
  2. Tricyclic antidepressants
  3. Benzodiazepines
  4. β-blockers

Although those were powerful for signs in lots of patients, a number of the drugs carried the chance of dependency, and a few can be very sedating. But benzodiazepines are nevertheless generally used. A long time subsequently, in the 1980s, croakers set up the benefits of SSRIs and SNRIs. They posed a significantly lower risk of addiction and resulted in fewer adverse outcomes for patients. These medications continue to be among the most widely used treatments for anxiety today. In recent years, both physicians and patients have recognized the value of integrating natural approaches with psychotherapy and pharmacotherapy. Holistic remedies are generally cautioned to patients to assist/ treat/ overcome anxiety signs, which include12

  1. Leisure and tranquillity strategies
  2. Yoga practice
  3. Diets that promote brain health

1.4.3 Abnormality diagnosis of anxiety

1.4.3.1 Pheochromocytoma

Phios = dusky; chroma = colour; and cytoma =   tumour.

Pheochromocytoma is a type of neuroendocrine tumor that originates from chromaffin cells, which are responsible for hormone production in the body. These cells are found within the adrenal glands, small organs situated at the upper region of the abdomen, atop the kidneys (fig 2)13

image

Figure 2: Illustrative diagram of Pheochromocytoma in kidney 13

  • Relation of pheochromocytoma with anxiety

Pheochromocytoma frequently motives the adrenal glands to launch greater catecholamine than ordinary, elevating blood stress and coronary heart rate. Less usually, pheochromocytoma can reason: anxiety and/or panic assaults14. 

  • Diagnosis of pheochromocytoma

Some people with pheochromocytoma have symptoms, but others don’t. Symptoms may also occur as often as numerous instances a day to more than one instance in step with month. Some people can also feel intense signs and symptoms that remaining for a quick time period, known as “paroxysmal assaults”. These signs and symptoms can encompass:

  1. Sweating
  2. High Blood Pressure
  3. Headaches
  4. Irregular Heartbeats

1.4.3.2 Asthma

Asthma is a chronic respiratory condition that impacts individuals of all ages. It results from inflammation and constriction of the muscles surrounding the airways, leading to difficulty in breathing due to increased contraction of airways and blockage (fig 3). Symptoms may include coughing, wheezing, shortness of breath, and chest tightness. These symptoms can vary in intensity and may fluctuate over time. While allergies can exacerbate the condition, effective management is possible with appropriate treatment. Individuals experiencing asthma symptoms should consult a healthcare professional16

image

Figure 3: Increased contraction of airways leading to blockage16.

  • Relation of asthma with anxiety

Anxiety and allergies have a bi-directional relationship, meaning each can cause or end result from the alternative. Anxiety can trigger bronchial asthma attacks, and allergies can growth the danger of anxiety problems17. Here are a few approaches tension and asthma is related:

• Anxiety can trigger asthma assaults: Anxiety can purpose bronchial asthma flare-ups, especially during acute assaults. Anxiety can also make people much more likely to react to their ordinary bronchial asthma triggers18, 19.

• Asthma can increase the threat of hysteria problems: People with allergies have a better chance of growing anxiety issues, mainly panic disorder20, 21.

• Anxiety could make it tougher to manage asthma: Anxiety could make it hard to take allergies medicines as prescribed, which can lead to worse bronchial asthma signs22, 23.

• Strong emotions can trigger asthma symptoms: Strong feelings like fear, anger, excitement, laughter, yelling, and crying can trigger asthma signs24.

  • Diagnosis of asthma

Your healthcare provider can also want to run a few exams to diagnose your allergies.

Lung function tests:

Lung feature tests degree how nicely you may breathe in and out:

Bronchodilator responsiveness tests measure how much higher you may blow air after breathing in a fast-acting bronchodilator, a remedy that helps open your airlines with the aid of enjoyable the muscle tissues around them. The test compares your spirometry or PEF outcomes before and after the drugs24.

Challenge tests:

Challenge checks, also called bronchial provocation assessments, determine how touchy your airways are. These checks evaluate how fast you can blow air before and after a venture agent. Challenge agents are substances or activities that can tighten the muscle mass for your airlines in the event that they emerge as irritated from being too sensitive, along with:

Other diagnostic tests:

Your healthcare practitioner may additionally want to run different checks to help diagnose your asthma. Some of them can also check your danger of allergies flare-america and expect how well you will reply to medicine:

Allergy tests can discover which allergens, such as puppy dander or pollen, purpose a reaction in your frame while you are around them. Your provider may additionally run these assessments if you have a history of allergies.

Key Note

Most diagnostic assessments for allergies do not work well for young kids. This could make it hard to diagnose allergies in children.

 

  • Management of Asthma

Preventing allergy attacks before they occur relies on effective prevention and long-term management strategies. Treatment typically involves understanding your triggers, taking measures to avoid them, and monitoring your respiratory health to ensure that your medications are effectively controlling symptoms. In the event of an asthma flare-up, it may be necessary to utilize a rescue inhaler25.

Medications:

The right medicinal drugs for you rely on a range of things — your age, symptoms, asthma triggers and what works great to preserve your bronchial asthma underneath manage. Precautionary, lengthy- term control specifics lessen the lump (vexation) in your airways that leads to signs and symptoms. Quick- relief inhalers (bronchodilators) offer quick open blown airways that are confining breathing. In a few cases, allergic reaction medicinal drugs are necessary26.

  1. Sustained management of asthma specifics: These generally taken day by day, are the foundation of bronchial asthma remedy. These specifics save bronchial asthma under manipulate on a diurnal base and make it much less likely you will have a bronchial asthma attack. Types of lengthy-term control medications encompass:
  2. Inhaled glucocorticoidsThese therapeutic agents include fluticasone propionate (Flovent HFA, Flovent Diskus, Xhance), budesonide (Pulmicort Flexhaler, Pulmicort Respules, Rhinocort), ciclesonide (Alvesco), beclomethasone (QvarRedihaler), mometasone (Asmanex HFA, Asmanex Twisthaler), and fluticasone furoate (Arnuity Ellipta). It is advisable to utilize these medications for several days to weeks to achieve their optimal benefits. In contrast to oral corticosteroids, inhaled corticosteroids present a significantly lower risk of severe side effects27.
  3. Leukotriene modifiersThese oral medicines — consisting of montelukast (Singulair), zafirlukast (Accolate) and zileuton (Zyflo) — help relieve allergies symptoms. Montelukast has been related to psychological reactions, along with agitation, aggression, hallucinations, melancholy and suicidal wondering. Seek scientific recommendation right away in case you enjoy any of those reactions28.
  4. Combination inhalersThese medications — along with fluticasone-salmeterol (Advair HFA, AirduoDigihaler, others), budesonide-formoterol (Symbicort), formoterol-mometasone (Dulera) and fluticasone furoate-vilanterol (Breo Ellipta) — incorporate a protracted-appearing β-agonist together with a corticosteroid29.
  5. TheophyllineTheophylline (Theo-24, Elixophyllin, Theochron) is a daily tablet that helps to keep the airways open by relaxing the muscles surrounding them. It is not as commonly used as other allergy medications and necessitates regular blood monitoring30.
  6. Quick-alleviation (rescue) medicinal drugsThese are used as needed for fast, short-term symptom comfort all through a bronchial asthma attack. They may also be used before exercise in case your doctor recommends it. Types of quick-remedy medicinal drugs encompass: Short-appearing β-agonists. These inhaled, brief-alleviation bronchodilators act within mins to hastily ease signs in the course of an allergies attack. They correspond of albuterol (ProAir HFA, Ventolin HFA, others) and levalbuterol (Xopenex, Xopenex HFA) 31.

Short-acting β-agonists: These can be taken using a transportable, handheld inhaler or a nebulizer, a machine that converts allergies medicines to a exceptional mist. They're inhaled via a face mask or mouthpiece. Anticholinergic dealers, like other bronchodilators, ipratropium (Atrovent HFA) and tiotropium (Spiriva, Spiriva Respimat) act quickly to without delay loosen up your airlines, making it easier to respire. They're generally used for emphysema and continual bronchitis however may be used to deal with allergies. These medicines which encompass prednisone (Prednisone Intensol, Rayos) and methylprednisolone (Medrol, Depo- Medrol, Solu-Medrol) — relieve airway inflammation as a result of extreme asthma. They can reason serious side consequences when used long term, so these capsules are used most effective on a quick-time period foundation to deal with severe bronchial asthma symptoms. If you've got an allergies flare-up, a short-comfort inhaler can ease your signs proper away. But you should not need to use your quick-remedy inhaler very frequently if your long-time period control medicinal drugs are operating well32.

1.4.3.3 Atrial fibrillation (AF)

Atrial fibrillation (AF) is the most common type of irregular heartbeat. The irregular electrical activity within the heart's chambers, as depicted in fig 4, leads to the gallerias fibrillating. This condition is categorized as a tachyarrhythmia, signifying that the heart rate is frequently fast and erratic. This type of arrhythmia may be acute or transient (lasting less than seven days) or chronic and persistent (exceeding seven days).

Irregularities in heart rhythm can lead to turbulent blood flow, increasing the risk of thrombus formation, which may ultimately dislodge and cause a stroke. Atrial fibrillation is the primary cardiac cause of stroke. Factors contributing to atrial fibrillation include advanced age, hypertension, pre-existing heart and lung conditions, congenital heart defects, and high alcohol consumption. Symptoms can range from none at all to those such as chest pain, palpitations, rapid heartbeat, shortness of breath, nausea, dizziness, excessive sweating, and overall fatigue. While atrial fibrillation can be a chronic condition, various treatments and risk management strategies have been developed to mitigate stroke risk in affected patients. These treatments encompass anticoagulation therapy, medications for rate control, rhythm control, cardioversion, ablation, and other interventional cardiac procedures33.


 

 

 

image

Figure 4: A healthy heart and a heart with atrial fibrillation33.


 
  • Relation of atrial fibrillation with Anxiety

Anxiety issues had been linked to the improvement and development of atrial fibrillation (AF), a situation that is inspired by means of the interplay among three factors: the arrhythmogenic substrate, trigger elements, and modulation elements. The autonomic apprehensive gadget performs an important function in AF, as it's largely accountable for the arrhythmogenic substrate, which leads to atrial fibrosis, myocyte apoptosis, and abnormal myocellular hypertrophy. These factors contribute to the anatomical arrhythmogenic substrate, resulting in a reduction and variation of the refractory period, a decrease in conduction velocity, and the development of re-entry circuits.

Inflammatory cytokines, such as C-reactive protein and interleukin-6, are independently associated with the risk of atrial fibrillation (AF). Research has demonstrated that anxiety and depression are connected to low-grade systemic inflammation, which may result in a higher incidence of cardiovascular events. The inflammatory condition observed in individuals with anxiety and depression is likely linked to hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, commonly seen in patients experiencing chronic stress.

Anxiety disorders can also cause extended hobby of the sympathetic frightened device and ultimately catecholamine overload that may trigger the onset of paroxysmal AF. Catecholamine load in pressure problems can beget the conformation of the arrhythmogenic substrate and spark the onset of ferocious AF. Anxiety disorders can trigger AF via the improved interest of the sympathetic apprehensive gadget, which is thought to be the maximum crucial modulation aspect of Coumel's triangle of arrhythmogenesis.

Individuals experiencing tension exhibit reduced heart rate variability and vagal tone, indicating abnormal autonomic regulation and posing an independent risk factor for atrial fibrillation. Furthermore, those with anxiety show heightened activity of the renin-angiotensin-aldosterone system (RAAS), which may contribute to atrial fibrosis and cardiac remodeling34.

  • Diagnosis of atrial fibrillation

A healthcare specialist will diagnose atrial fibrillation based totally for your medical and own family history, a physical examination, the results from an electrocardiogram (ECG), and possibly different assessments and methods. If you are diagnosed with atrial fibrillation, your provider can investigate any underlying conditions that may be contributing to it and assess your risk of developing dangerous blood clots. This will assist in formulating the most effective treatment plan for you.

Screening methods:

Screening, which involves assessing for symptoms and risk factors, enables healthcare providers to determine the necessity of diagnostic evaluations. Your healthcare provider may screen for atrial fibrillation only if you present with risk factors. However, they may also assess for signs of atrial fibrillation as part of your routine hospital care. Additionally, your provider might recommend lifestyle modifications to help mitigate your risk of developing atrial fibrillation. Screening procedures may be included in your regular care if you are 65 years or older or possess other risk factors. Your provider may evaluate your heart rate for any irregularities or unusual rhythms even in the absence of symptoms.

Your healthcare specialist will ask approximately your consuming and physical hobby conduct, circle of relative’s history, and other risk factors for atrial traumatic inflammation and heartsickness. You will also be asked whether you have some other symptoms. These facts can assist your company to determine whether or not you have different conditions that can be causing you to have atrial fibrillation35.

Medical history:

Your healthcare provider will inquire about your dietary and physical activity habits, family history, and various risk factors associated with atrial fibrillation and heart disease. Additionally, you may be questioned about any other symptoms you may be experiencing. This information can assist your provider in determining if there are other conditions contributing to your atrial fibrillation36.

Physical examination:

Your provider will conduct a thorough physical examination, with particular focus on your cardiovascular and respiratory systems. During this assessment, they will:

Assessment examinations:

Diagnostic evaluations for identifying atrial fibrillation will likely include one or more cardiac or blood tests conducted by your company.

Other examinations:

Your healthcare provider may also request additional tests to identify unusual heart rhythms that occur under specific circumstances or outside the medical facility, assess the presence of atrial inflammatory conditions or any other arrhythmias, and determine the most effective treatment.

A walking assessment evaluates your heart's performance during a six-minute walk. This can assist in determining how well your body regulates its heart rate under normal conditions39.

 

  • Treatment of atrial fibrillation

Atrial traumatic inflammation is treated with life-style adjustments, drug treatments, and tactics, together with surgery, to assist prevent blood clots, gradual your heartbeat, or repair your coronary heart’s regular rhythm. Your physician might also treat you for an underlying ailment this is raising the risk of atrial traumatic inflammation, inclusive of obese or obesity, sleep apnoea, or an overactive thyroid gland.

Medicines:

Your healthcare provider may additionally recall treating your atrial fibrillation with medicines that assist prevent blood clots from forming and drugs that paintings via slowing your heart rate or by restoring your heart’s normal rhythm.

Procedures and/or surgery:

Your healthcare provider may additionally recommend a system, mainly if life-style adjustments and medicine by me no longer improve your symptoms. Typically, your company will remember a surgical operation to deal with your atrial traumatic inflammation simplest if you may be having surgical operation to treat some other heart situation. This can be accomplished in an emergency or if medicines have not worked.

 

1.4.3.4 Hyperthyroidism

Hyperthyroidism, additionally called overactive thyroid, is when the thyroid gland makes extra thyroid hormones than your frame needs (fig 5). The thyroid is a small gland shaped like a butterfly, located at the front of the neck. Thyroid hormones manage the way the frame makes use of strength, in order that they affect nearly every organ on your frame, even the way your heart beats. With too much thyroid hormone, a lot of your body’s features accelerate45.

image

Figure 5: Hyperthyroidism46 

  • Relation of hyperthyroidism with anxiety

Hyperthyroidism can show up with tension-like signs, mimicking psychiatric problems together with General Anxiety Disorder (GAD). The shared symptoms in these scenarios can lead to misdiagnosis and incorrect management of the underlying medical condition. Timely recognition and evaluation of thyroid function is crucial, particularly in cases of unusual or treatment-resistant anxiety disorders. In addition to a psychological assessment, a thorough clinical evaluation, including a physical examination and relevant laboratory tests, should be conducted for patients exhibiting anxiety-like symptoms46.

  • Diagnosis of hyperthyroidism

When assessing you for hyperthyroidism, your healthcare provider will gather your personal and family medical history and perform a physical examination. Physicians typically diagnose hyperthyroidism based on symptoms, clinical findings, and laboratory tests. These diagnostic evaluations consist of:

T4, free T4, and T3 stage tests: These assessments evaluate the levels of thyroid hormones (T4 and T3) present in your bloodstream47.

Thyroid- stimulating hormone (TSH) position test: The thyroid-stimulating hormone (TSH) position test assesses the levels of TSH, a hormone produced by the pituitary gland that prompts the thyroid gland to generate hormones. In cases where thyroid hormone levels are elevated, the pituitary gland decreases TSH production as a response. An unusually low TSH level may indicate the onset of hyperthyroidism48.

Thyroid scan (Radioactive iodine uptake scan): This process allows the doctor to assess whether the thyroid is overactive by evaluating the quantity of iodine it takes in from your blood. The doctor will provide a small dose of iodine, either as a tablet or in liquid form. Afterward, you will recline on a table while a specialized camera takes images of your thyroid. In particular, a thyroid test can determine if the entire gland or only a specific region is causing the problem49

Ultrasound of thyroid: Ultrasound imaging can assess the size of the entire thyroid gland and identify any masses present, including nodules. Additionally, physicians can utilize ultrasounds to ascertain whether a mass is solid or cystic50

CT or MRI scans: A CT scan or MRI can reveal the presence of a pituitary tumor.

  1. Although primary care physicians are able to request certain tests, it is advisable to consult an endocrinologist. Endocrinologists are experts in the treatment and management of health issues related to hormones51
  2. Treatment of hyperthyroidism

Medication:

Anti-thyroid medications inhibit the production of hormones by the thyroid gland. The most commonly used anti-thyroid medications belong to a class known as Thionamides, which includes the drugs methimazole (MMI) and propylthiouracil (PTU).

Thionamides have been utilized for the treatment of hyperthyroidism for several years and are generally considered safe for both children and adults, including those who are pregnant. Nonetheless, anti-thyroid drugs can result in negative side effects including joint discomfort, hair thinning, and skin rashes. In uncommon cases, they may also cause liver damage. It is crucial to notify your doctor if you are pregnant, intend to become pregnant, or are currently on other medications. Always follow the medication schedule as directed by your physician (Lights V. Hyperthyroidism)52

Radioactive iodine:

Radioactive iodine (RAI), commonly referred to as radioiodine, effectively eliminates the cells responsible for producing thyroid hormones while sparing other tissues in the body. It is typically administered in the form of an oral pill or liquid. Most patients receiving radioiodine treatment for hyperthyroidism subsequently develop hypothyroidism, which is generally more manageable and requires daily thyroid hormone supplementation. Additionally, RAI is utilized in higher doses for the treatment of thyroid cancer. In rare instances, prolonged exposure to elevated doses of RAI has been associated with an increased risk of certain cancers; however, this correlation has not been observed with the lower doses used for hyperthyroidism treatment. Side effects may occur with RAI therapy, particularly at higher doses, and can include neck pain, nausea, and dry mouth. Furthermore, high-dose RAI treatment may also affect fertility53

Surgery:

A thyroidectomy involves the removal of all or part of the thyroid gland. This surgical procedure may be recommended for certain individuals with hyperthyroidism, but it is assessed on a case-by-case basis. Surgery may be necessary for patients who do not respond to other treatment options or are unable to undergo them. The removal of the thyroid gland is also utilized to address various forms of thyroiditis, thyrotoxicosis, and thyroid cancer. However, if the entire thyroid gland is removed, lifelong thyroid hormone supplementation may be required. The medication levothyroxine (marketed under brand names such as Levoxyl and Synthroid) is a synthetic version of the thyroid's T4 hormone and is typically prescribed in tablet form. This medication helps prevent hypothyroidism, a condition characterized by an underactive thyroid that produces insufficient hormone levels. As with any surgical procedure, thyroid removal carries certain risks and potential complications. The surgical procedure is generally carried out with the aid of an endocrine health care provider, otolaryngologist, or standard doctor54

1.4.3.5 Alcoholism

Alcoholism is a continual disorder wherein a person craves liquids that comprise alcohol (fig 6) and is not able to manipulate his or her ingesting. A man or woman with this sickness additionally needs to drink more quantities to get the equal impact and has withdrawal signs after stopping alcohol use. Alcoholism impacts bodily and intellectual health, and might purpose problems with own family, pals, and work. Regular heavy alcohol input will increase the chance of numerous styles of cancer. It is also referred to as alcohol dependence55

image

Figure 6: Alcoholism56

Relation of alcoholism with anxiety

Anxiety ailment and alcohol use disease are commonplace co-taking place issues that can motive extreme distress and impair your daily functioning. Alcohol use complaint can complicate an current anxiety sickness or may also lead to new pressure signs and vice versa, that means that a pre-present anxiety complaint can contribute to an alcohol use ailment (as many individuals use alcohol as an dangerous coping mechanism)56

The consumption of alcohol may lead to the development of new anxiety disorders and exacerbate existing anxiety symptoms. Many individuals resort to alcohol as an ineffective coping mechanism to alleviate feelings of stress. While alcohol may provide temporary relief from tension and distract from underlying issues, it does not eliminate these root causes.

Regardless of whether your anxiety stems from past trauma, financial difficulties, or unresolved depression, alcohol serves only as a temporary solution. The more one depends on alcohol to alleviate their anxiety, the higher the risk of developing an alcohol use disorder. Furthermore, the symptoms of anxiety will continue to persist, as the root causes have not been adequately addressed. Long-term alcohol consumption affects your ability to cope with stress in healthy and constructive manners, potentially leading to increased tension. This influence may stem from alcohol's impact on the amygdala, the brain region responsible for managing negative emotions. Neuroimaging studies have identified irregularities in amygdala activity among individuals diagnosed with alcohol use disorder57

Diagnosis of alcoholism

Alcohol use complaint is a prognostic made with the aid of our educated clinicians. A prognosis of alcohol use ailment can encompass a number of the subsequent eleven standards:

consuming to keep away from those signs alcohol use sickness can encompass periods of alcohol intoxication and signs and symptoms of withdrawal treatment58, 59

Question: Do all types of alcohol cause anxiety?

Answer: Alcohol consumption does not necessarily impact anxiety levels, but rather the quantity and frequency of alcohol use, not the type of alcohol. Wine and beer may cause less anxiety due to their alcohol content. (LMSW SM: Alcohol Anxiety).

 

Treatment of alcoholism

Alcoholism can be treated in following ways:

Behavioural treatments: Behavioural remedies are aimed toward changing ingesting behaviour through counselling. They are led by using health care companies and supported via research displaying that those remedies can be beneficial.

Medications: Three medicinal drugs are presently permitted within the United States to help patients forestall or lessen their ingesting and prevent a return to ingesting. These medications are prescribed with the aid of a number one care company or other fitness care issuer and can be used alone or in aggregate with counselling.

Mutual support groups: Alcoholics Anonymous® (also called "AA") and different 12-step applications provide peer support for patients quitting or slicing lower back on their ingesting. Combined with remedy led with the aid of fitness care providers, collective- support groups can give a precious added subcaste of aid. The evidence indicates that the unfastened and bendy help furnished by mutual-help businesses can assist people make and sustain beneficial adjustments and, accordingly, promote restoration.

Medications: Some people are amazed to examine that there are medicines on the market approved to treat alcoholism. The newer styles of these specifics work by means of negative adaptations in the mind as a result of drunkenness. All accredited medications are nonaddictive and can be used alone or in combination with other types of treatment. Ultimately, selecting to get remedy can be greater critical than the approach used as long as the method avoids heavy confrontation and incorporates empathy, motivational assist, and a focal point on converting consuming conduct.

Medications available for alcoholism: Currently, there are 3 medicinal drugs authorised for AUD, and they're a powerful and crucial aid inside the remedy of people with this situation.

  1. Naltrexone is to be had as a pill or injection and allows lessen the urge to drink.
  2. Acamprosate is a tablet that decreases the poor signs and symptoms which might be on occasion felt in the course of abstinence from alcohol, making abstinence less difficult to preserve.
  3. Disulfiram is a tablet that daunts drinking by using inflicting ugly signs when alcohol is ate up60

Given the numerous organic tactics that make a contribution to alcoholism, new medicines are hard to provide a broader spectrum of remedy alternatives. Just like every other scientific situation, people with substance use problems should have various remedy options available to them. Scientists are running to expand a bigger menu of pharmaceutical remedies that would be tailor-made to man or woman desires.

Ideally, providers of fitness care will eventually possess the ability to determine which AUD treatment is exclusively suitable for each individual. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is facilitating research aimed at identifying genetic, behavioral, and other factors that may predict an individual's response to a particular treatment. These advancements could enhance the process of making treatment decisions in the future61

1.5 Measurement of stress level in people

Measuring stress includes assessing someone’s physiological responses to stressors and, to a lower extent, information the doable triggers for pressure. Measuring stress may also help someone or their healthcare group determine whether or not the stairs they may be taking to manage pressure are running. Stress dimension entails know-how what worrying activities someone may be dealing with and how their frame responds to the specific stressors. A dimension of perceived strain can also assist show how plenty strain someone is feeling.

Measuring strain involves inspecting its factor components. Stress includes triggers and someone’s reaction to those triggers. Alarms can correspond of plenitude of occasions, from acute conditions to habitual conditions. Examples of acute conditions encompass:

Examples of chronic conditions include:

The number of annoying activities or triggers a person is experiencing may additionally influence their stress levels. However, all people’s reaction to triggers plays a doubtlessly larger position in the quantity of strain they revel in. For example, one individual may additionally locate it overwhelming to be a caregiver for a cherished one, whilst every other man or woman won't have any essential difficulties with that revel in. As a result, the second character may additionally have less universal stress. Stress measurement regularly entails assessing a person’s perceived stress and the physiological adjustments they experience62

1.5.1 Perceived stress scale

The Perceived Stress Scale (PSS) is a 10-query self-evaluation that asks a person to rate the amount of stress they feel with a rating of 0-4. A higher total rating suggests that someone is experiencing a larger amount of stress. While probably beneficial in self-assessing pressure levels for a person managing an annoying event, the PSS can't offer an analysis or guidance on remedy63

1.5.2 Brainwave tests

In a 2020 study, the scientists checked out how measured brainwaves from an electro-encephalography (EEG) test may indicate stress tiers. They located that alpha asymmetry can be a legitimate and useful biomarker of stress. Alpha asymmetry is an imbalance of alpha mind waves on either side of the brain64

1.5.3 Assessment of heart rate variability

Heart rate variability (HRV) refers to the variations in the intervals between heartbeats. The heart instinctively modifies the timing of these beats in response to sudden physical and emotional changes. The autonomic nervous system (ANS) regulates HRV, comprising both the sympathetic nervous system (SNS), which governs the fight-or-flight response, and the parasympathetic nervous system (PNS), which is active during periods of relaxation. Habitual pressure reasons the sympathetic nervous system to get hyperactive. When this takes place, it brings changes in HRV, which scientists propose might also help measure stress situations. Doctors can measure HRV the usage of an electrocardiogram and distinct wearable devices65

1.5.4 Hormone level testing

The ANS is responsible for regulating the release of cortisol and adrenaline. These hormones are integral to the fight-or-flight response triggered by stress. Adrenaline provides the body with a surge of energy, whereas cortisol helps to shut down non-essential functions. Numerous studies have indicated that cortisol levels may rise during stressful times; however, they can also remain stable. This variability renders cortisol levels an unreliable indicator of stress, although they can still offer valuable insights into potentially harmful cortisol concentrations in the bloodstream. A physician can assess cortisol levels through a saliva or blood sample, or an individual may opt for an at-home testing kit66

1.6 Levels of anxiety

Anxiety problems are not unusual, but there's a wide variation in symptom severity. Some people revel in milder impairment, whereas others stay with complete-blown panic signs that considerably intervene with every day functioning. The severity of tension can depend upon several factors, together with the form of tension ailment a person has. For instance, research indicates that panic disorder and generalized tension sickness are probable to purpose severe function impairment. Furthermore, genetic elements can boom the threat of severe tension. The four tiers (Table 1) of hysteria classifications come from the impairment and misery someone experiences each day67

1.6.1 Mild anxiety

Approximately 50% of patients suffering from anxiety disorders experience mild levels of distress. 43.5% of adults with a stress-related condition report moderate stress. Those in this group may occasionally exhibit poor coping strategies, yet their symptoms typically do not significantly disrupt daily functioning68

1.6.2 Moderate anxiety

Moderate pressure affects 33.7% of individuals experiencing anxiety disorders. When the tension is moderate, it tends to be more persistent than mild tension. Those exhibiting mild tension symptoms may struggle with daily activities such as working or socializing. They might also benefit from medication to alleviate symptoms or from consulting a therapist to enhance their coping strategies69

1.6.3 Severe anxiety

Severe anxiety, which is greater debilitating than mild or mild signs and symptoms, is seen in 22.8% of people with anxiety disorders. An individual with excessive anxiety might also require in depth mental health services, and preserving a task or having healthy relationships may be difficult. Compared to those with milder forms of anxiety, those with intense impairment may additionally meet more diagnostic standards for tension sickness, which means they show greater symptoms. Severe anxiety is likewise associated with co-happening depression69. 

1.6.4 Panic level anxiety

In extreme instances, tension could make a person sense out of manipulate; in this situation, they will have a panic attack. A panic assault refers to an intense length of fear in the course of which a person experiences signs which include a racing coronary heart, sweating, trembling, chest ache and a feel that something horrible is set to happen. These assaults are surprising and can arise and not using a clear danger or trigger. Panic attacks usually endure for just a few minutes. When these attacks occur frequently, an individual is diagnosed with panic disorder. Sometimes, a particular fear, such as the fear of being confined, can trigger a panic attack. For example, in the case of agoraphobia, a person may also experience a panic attack while using public transport, participating in a crowded event, or being in an enclosed space70.


 

 

Table 1: Levels of Anxiety with characteristic features71

Mild Anxiety

Moderate Anxiety

Severe Anxiety

Panic Level Anxiety

Half of anxiety patients experience mild misery.

33.7% of anxiety issues suffer from moderate tension.

Found in 22.8% of anxiety disorder patients.

It refers to intense fear causing symptoms like racing heart, sweating, trembling, chest pain, and a sense of imminent danger and can occur without a clear threat or trigger, often lasting only a few minutes.

43.5% of adults with tension disorder have moderate tension.

Moderate tension is more chronic than slight tension.

May require in-depth mental health services.

Recurrent panic attacks are diagnosed as panic disorder.

Individuals may have bad coping mechanisms, but symptoms don't significantly impact daily functioning.

Mild tension can cause distress in daily activities.

Difficulty in maintaining tasks or maintaining relationships.

Specific fears, like fear of being trapped, can cause panic attacks.

 

Medications or therapy may help manage symptoms.

More severe cases may meet more diagnostic standards for tension sickness and co-occurring depression is also common.

Afraid of public transportation, crowded events, or closed areas can also trigger panic attacks.

 

 

 


 

1.7 Managing anxiety

Anxiety can be controlled using quite a few self-assist strategies, as well as professional interventions. In instances of moderate tension, someone may be capable of deal with it by means of using a self-care method. For instance, research suggests that exercise is beneficial for alleviating anxiety signs.

If your signs are moderate, bodily activities like jogging or cycling can be enough for managing signs and symptoms. In extra excessive forms of tension, exercise can supplement expert treatment. Stress control strategies, such as revolutionary muscle relaxation (PMR), can also be beneficial for lowering anxiety signs, inclusive of panic. Tighten the muscle group, holding the contraction for duration of 5 to 7 seconds. Subsequently, release and focus on the feeling of relaxation for 20 seconds before transitioning to the posterior muscle group. Mindfulness meditation may also be beneficial for mild to moderate anxiety, whether practiced independently as a self-help method or as a complement to professional treatments, including therapy. Mindfulness techniques can assist individuals in focusing on the present moment instead of allowing their thoughts to drift towards various concerns72.

When self-care techniques are not enough, expert remedy assist you to overcome anxiety symptoms. Anxiety is usually dealt with therapy, medicinal drug or a combination of the two. Considering the subsequent remedy techniques:

1.7.1 Medication

Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), benzodiazepines, tricyclic antidepressants, mild tranquilizers, and β-blockers are effective in addressing anxiety disorders73.

1.7.2 Therapy

Cognitive-behavioral therapy (CBT) is recognized as one of the most effective forms of psychotherapy. It is a structured, goal-oriented, and educational approach that aims to assist individuals in identifying and altering maladaptive thought patterns and beliefs that contribute to and sustain symptoms. This type of therapy emphasizes the development of behavioral skills, enabling patients to respond and act more adaptively in anxiety-provoking situations. Exposure therapy is applied to move people closer to going through the anxiety-scary conditions and stimuli that they generally keep away from. This exposure leads to a decrease in signs and symptoms of anxiety, as individuals discover that their anxiety compels them to engage in false warnings. Consequently, they no longer need to be concerned about the situation or stimuli, allowing them to effectively manage such scenarios74.

  1. Discussion

Investigation has examined biomarkers associated with steroids and their derivatives concerning specific forms of distress or the particular metabolites under investigation. Moreover, studies focusing on biomarkers linked to well-established pathways that regulate stress responses, such as cortisol management, have yielded inconsistent results. Additionally, variations in findings were observed across multiple classes of metabolites in relation to different types of distress, including catecholamine metabolites, serotonin and its derivatives, along with amino acids. Simultaneously, when contrasting various forms of distress, there was suggestive evidence pointing to consistent associations between fatty acids and different types of distress 75, 76, 77.

  1. Conclusion and Future Prospectives

Metabolomic markers are becoming a groundbreaking tool for better understanding and managing anxiety disorders. These disorders, characterized by feelings of fear, worry, and a fight-or-flight response to perceived threats, often involve complex emotional, physical, and behavioural reactions. Metabolomics, which studies the small molecules within cells, helps uncover the biochemical changes associated with anxiety disorders. It highlights the role of neurotransmitters like nor-epinephrine, serotonin, and GABA, as well as biomarkers such as cortisol, in driving these conditions.

This approach is especially valuable as it not only enhances diagnostic accuracy but also creates a bridge between scientific research and clinical treatment. By identifying specific metabolic disruptions, doctors can better understand the underlying causes of anxiety and develop more personalized treatment plans. Conventional therapies, including cognitive-behavioral therapy (CBT), pharmacological treatments, and modifications in lifestyle, may be greatly enhanced by incorporating metabolomic insights. These markers could allow for early diagnosis, help monitor the effectiveness of treatments, and track the progression of the disorder over time.

Looking ahead, combining metabolomics with other fields, such as genetics and environmental studies, could pave the way for a more comprehensive understanding of anxiety disorders. Additionally, incorporating artificial intelligence into this research could speed up discoveries and improve the precision of personalized treatments. This rapidly growing field offers hope for developing more effective therapies and tailored care, ultimately transforming how anxiety disorders are understood and treated.

Author’s Contributions: Vandana Gupta supervised the work, contributed to conceptualization and literature collection. Noopur Srivastava contributed to the drafting of the manuscript and data interpretation. Both authors critically revised the manuscript, and approved the final version. 

Funding Source: Present investigation did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. 

Conflict of Interest: The authors declare no conflict of interest.

Ethical Approval: Not applicable. 

References

  1. Craske MG, Rauch SL, Ursano R, Prenoveau J, Pine DS, Zinbarg RE. What is an anxiety disorder?. Focus. 2011 Jul;9(3):369-88. https://doi.org/10.1176/foc.9.3.foc369 
  2. Aragon A, Kings J, Playford ED. The role of occupational therapy in the rehabilitation of people with movement disorders. Rehabilitation in Movement Disorders. 2013 May 23:69. https://doi.org/10.1017/CBO9781139012942.008 
  3. Gentes EL, Ruscio AM. A meta-analysis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive–compulsive disorder. Clinical psychology review. 2011 Aug 1;31(6):923-33. https://doi.org/10.1016/j.cpr.2011.05.001 
  4. Martin P. The epidemiology of anxiety disorders: a review. Dialogues in clinical neuroscience. 2003 Sep 30;5(3):281-98. https://doi.org/10.31887/dcns.2003.5.3/pmartin 
  5. Madonna D, Delvecchio G, Soares JC, Brambilla P. Structural and functional neuroimaging studies in generalized anxiety disorder: a systematic review. Brazilian Journal of Psychiatry. 2019 May 16;41:336-62. https://doi.org/10.1590/1516-4446-2018-0108 
  6. Ustinova Y, Cardeña E. Combat stress disorders and their treatment in ancient Greece. Psychological trauma: Theory, research, practice, and policy. 2014 Nov;6(6):739. https://psycnet.apa.org/doi/10.1037/a0036461 
  7. Agyapong B, Shalaby R, Hay K, Pattison R, Eboreime E, Korthuis M, Wei Y, Agyapong VI. Exploring sociodemographic characteristics, adverse childhood experience, and mental health history as predictors of anxiety and depression among adolescents and young adults: findings from the MoreGoodDays support program in Alberta, Canada. Behavioral Sciences. 2023 Sep 8;13(9):749. https://doi.org/10.3390/bs13090749
  8. Rosqvist J. Exposure treatments for anxiety disorders: A practitioner's guide to concepts, methods, and evidence-based practice. Routledge; 2012 Oct 12. https://doi.org/10.4324/9780203843833 
  9. Lazarus RS. Cognition and motivation in emotion. American psychologist. 1991 Apr;46(4):352. https://psycnet.apa.org/doi/10.1037/0003-066X.46.4.352 
  10. Sitzman K, Watson J. Caring science, mindful practice: Implementing Watson’s human caring theory. Springer Publishing Company; 2018 Apr 28. http://dx.doi.org/10.1177/0894318414534468 
  11. Baldessarini RJ. Drug therapy of depression and anxiety disorders. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Edited by Brunton LL, Lazo JS, Parker KL. New York, McGraw-Hill. 2006:429-60.
  12. Leahy RL, Holland SJ, McGinn LK. Treatment plans and interventions for depression and anxiety disorders. Guilford press; 2011 Oct 26.
  13. Kantorovich V, Pacak K. Pheochromocytoma and paraganglioma. Progress in brain research. 2010 Jan 1;182:343-73. https://doi.org/10.1016/s0079-6123(10)82015-1 
  14. Alguire C, Chbat J, Forest I, Godbout A, Bourdeau I. Unusual presentation of pheochromocytoma: thirteen years of anxiety requiring psychiatric treatment. Endocrinology, Diabetes & Metabolism Case Reports. 2018 Apr 6;2018(1). https://doi.org/10.1530/edm-17-0176 
  15. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F. Pheochromocytoma: an update on genetics and management. Endocrine-related cancer. 2007 Dec 1;14(4):935-56. https://doi.org/10.1677/erc-07-0142 
  16. Lehrer P, Feldman J, Giardino N, Song HS, Schmaling K. Psychological aspects of asthma. Journal of consulting and clinical psychology. 2002 Jun;70(3):691. https://doi.org/10.1037//0022-006x.70.3.691 
  17. Ten Thoren C, Petermann F. Reviewing asthma and anxiety. Respiratory medicine. 2000 May 1;94(5):409-15. https://doi.org/10.1053/rmed.1999.0757 
  18. Deshmukh VM, Toelle BG, Usherwood T, O’Grady B, Jenkins CR. Anxiety, panic and adult asthma: A cognitive-behavioral perspective. Respiratory medicine. 2007 Feb 1;101(2):194-202. https://doi.org/10.1016/j.rmed.2006.05.005 
  19. Gautier C, Charpin D. Environmental triggers and avoidance in the management of asthma. Journal of asthma and allergy. 2017 Mar 7:47-56. https://doi.org/10.2147/jaa.s121276 
  20. Polloni L, Muraro A. Anxiety and food allergy: a review of the last two decades. Clinical & Experimental Allergy. 2020 Apr;50(4):420-41. https://doi.org/10.1111/cea.13548 
  21. Hsieh MT, Liang SH, Yang YH, Kuo TY, Lin TY, Wang TN, Chen VC, Wu MH. Allergic rhinitis increases the risk of incident panic disorder among young individuals: a nationwide population-based cohort study in Taiwan. Journal of affective disorders. 2019 Jun 1;252:60-7. https://doi.org/10.1016/j.jad.2019.04.037 
  22. Stauder, A. and Kovács, M., 2003. Anxiety symptoms in allergic patients: identification and risk factors. Biopsychosocial Science and Medicine, 65(5), pp.816-823. https://doi.org/ 10.1097/01.PSY.0000088620.66211.B1 
  23. Lehrer P, Feldman J, Giardino N, Song HS, Schmaling K. Psychological aspects of asthma. Journal of consulting and clinical psychology. 2002 Jun;70(3):691. https://doi.org/10.1037//0022-006x.70.3.691 
  24. Lehrer PM, Isenberg S, Hochron SM. Asthma and emotion: a review. Journal of Asthma. 1993 Jan 1;30(1):5-21. https://doi.org/10.3109/02770909309066375 
  25. Clark D. Herbal Healing for Children: A Parent's Guide to Treatments for Common Childhood Illnesses. Book Publishing Company; 2011 Apr 5.
  26. Mahler DA. Breathe Easy: Relieving the Symptoms of Chronic Lung Disease. University Press of New England; 2017 Jun 6.
  27. Ye Q, He XO, D’Urzo A. A review on the safety and efficacy of inhaled corticosteroids in the management of asthma. Pulmonary Therapy. 2017 Jun; 3:1-8. https://doi.org/10.1007/s41030-017-0043-5
  28. Rosenberg M. Born with a Junk Food Deficiency: How Flaks, Quacks, and Hacks Pimp the Public Health. Prometheus Books; 2012 Apr 10.
  29. Alangari AA. Corticosteroids in the treatment of acute asthma. Annals of thoracic medicine. 2014 Oct 1;9(4):187-92. https://doi.org/10.4103/1817-1737.140120 
  30. Rogliani P, Calzetta L, Ora J, Cazzola M, Matera MG. Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis. Multidisciplinary Respiratory Medicine. 2019 Dec;14:1-8. https://doi.org/10.1186/s40248-019-0189-0 
  31. Nanda A, Russell AF, Bingemann TA. Pharmacology update: emergency and controller medications for treatment of asthma. NASN School Nurse. 2022 Jan;37(1):31-5. https://doi.org/10.1177/1942602x211036933 
  32. Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, Cazzola M. Severe asthma and biological therapy: when, which, and for whom. Pulmonary therapy. 2020 Jun;6:47-66. https://doi.org/10.1007/s41030-019-00109-1 
  33. Lévy S, Steinbeck G, Santini L, Nabauer M, Maceda DP, Kantharia BK, Saksena S, Cappato R. Management of atrial fibrillation: Two decades of progress—A scientific statement from the European Cardiac Arrhythmia Society. Journal of Interventional Cardiac Electrophysiology. 2022 Oct;65(1):287-326. https://doi.org/10.1007/s10840-022-01195-z 
  34. Ahmed M. Chronic cardiac diseases and patients’ mental health: Exploring the impact of improving mental health on chronic heart failure prognosis and adherence to treatment behaviour in primary care based patients.
  35. Cousineau JP, Dawe AM, Alpaugh M. Investigating the Interplay between Cardiovascular and Neurodegenerative Disease. Biology. 2024 Sep 26;13(10):764.  https://doi.org/10.3390/biology13100764 
  36. Wang Z, Yang B. Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology. InPolypharmacology: Principles and Methodologies 2022 Aug 2 (pp. 133-198). Cham: Springer International Publishing. http://dx.doi.org/10.1007/978-3-031-04998-9_4 
  37. Caldentey G, Khairy P, Roy D, Leduc H, Talajic M, Racine N, White M, O'Meara E, Guertin MC, Rouleau JL, Ducharme A. Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure). JACC: Heart Failure. 2014 Feb;2(1):15-23. https://doi.org/10.1016/j.jchf.2013.10.004 
  38. Haemers P, Claus P, Willems R. The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation. Cardiology research and practice. 2012;2012(1):658937. https://doi.org/10.1155/2012/658937 
  39. Bonnesen MP, Frodi DM, Haugan KJ, Kronborg C, Graff C, Højberg S, Køber L, Krieger D, Brandes A, Svendsen JH, Diederichsen SZ. Day-to-day measurement of physical activity and risk of atrial fibrillation. European heart journal. 2021 Oct 7;42(38):3979-88. https://doi.org/10.1093/eurheartj/ehab597 
  40. Mittal T. Pacemakers—A journey through the years. Indian Journal of Thoracic and Cardiovascular Surgery. 2005 Sep;21:236-49. https://doi.org/10.1007/s12055-005-0060-0 
  41. Czick ME, Shapter CL, Silverman DI. Atrial fibrillation: the science behind its defiance. Aging and disease. 2016 Oct 1;7(5):635. https://doi.org/10.14336/AD.2016.0211 
  42. Cannon CP, Vierck E. The New Heart Disease Handbook: Everything You Need to Know to Effectively Reverse and Manage Heart Disease. Fair Winds Press; 2009 Sep 1.
  43. Regazzoli D, Ancona F, Trevisi N, Guarracini F, Radinovic A, Oppizzi M, Agricola E, Marzi A, Sora NC, Della Bella P, Mazzone P. Left atrial appendage: physiology, pathology, and role as a therapeutic target. BioMed research international. 2015;2015(1):205013. https://doi.org/10.1155/2015/205013 
  44. Michniewicz E, Mlodawska E, Lopatowska P, Tomaszuk-Kazberuk A, Malyszko J. Patients with atrial fibrillation and coronary artery disease–double trouble. Advances in medical sciences. 2018 Mar 1;63(1):30-5. https://doi.org/10.1016/j.advms.2017.06.005 
  45. Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. Journal of affective disorders. 2002 May 1;69(1-3):209-17. https://doi.org/10.1016/s0165-0327(01)00378-0
  46. Shoib S, Ahmad J, Wani MA, Ullah I, Tarfarosh SF, Masoodi SR, Ramalho R. Depression and anxiety among hyperthyroid female patients and impact of treatment. Middle East Current Psychiatry. 2021 Jun 8;28(1):26. https://doi.org/10.1186/s43045-021-00107-7 
  47. Salman AG, Mahdi IA, Mukhlef AK, abdalsattar Mohammad R, Zaghir MS, muatezWadaa'a N. Physiological aspects of thyroid disorders: Anatomy, hormones, diagnosis and management. Current Clinical and Medical Education. 2024 May 2;2(5):17-32.
  48. Fountoulakis KN, Iacovides A, Grammaticos P, St Kaprinis G, Bech P. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC psychiatry. 2004 Dec;4:1-9. https://doi.org/10.1186/1471-244X-4-6 
  49. Askari E, Saidi B, Evangelista L. Indications for diagnostic whole-body iodine scan: a review of guidelines. Nuclear Medicine Communications. 2024 Dec 1;45(12):998-1006. https://doi.org/10.1097/MNM.0000000000001906
  50. Stohn JP, Martinez ME, Hernandez A. Decreased anxiety-and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism. Psychoneuroendocrinology. 2016 Dec 1;74:46-56. https://doi.org/10.1016/j.psyneuen.2016.08.021 
  51. Holtorf K. Peripheral thyroid hormone conversion and its impact on TSH and metabolic activity. Journal of Restorative medicine. 2014 Apr 1;3(1):30. http://dx.doi.org/10.14200/jrm.2014.3.0103
  52. Lee SY, Pearce EN. Hyperthyroidism: a review. Jama. 2023 Oct 17;330(15):1472-83. https://doi.org/10.1001/jama.2023.19052
  53. Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinology and metabolism clinics of North America. 1998 Mar 1;27(1):205-23. https://doi.org/10.1016/s0889-8529(05)70307-8
  54. Lee SY, Pearce EN. Hyperthyroidism: a review. Jama. 2023 Oct 17;330(15):1472-83.
  55. Rehm J. The risks associated with alcohol use and alcoholism. Alcohol Research & Health. 2011;34(2):135.
  56. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship?. Focus. 1994 Jul;151(3):1723-453. https://doi.org/10.1176/ajp.151.12.1723 
  57. Chambless DL, Cherney J, Caputo GC, Rheinstein BJ. Anxiety disorders and alcoholism:: A study with inpatient alcoholics. Journal of Anxiety Disorders. 1987 Jan 1;1(1):29-40.
  58. Clark DB, Sayette MA. Anxiety and the development of alcoholism: Clinical and scientific issues. American Journal on Addictions. 1993 Jan 1;2(1):59-76. https://doi.org/10.1111/j.1521-0391.1993.tb00371.x 
  59. Johnson BA. Medication treatment of different types of alcoholism. American Journal of Psychiatry. 2010 Jun 1;167(6):630-9. https://doi.org/10.1176/appi.ajp.2010.08101500 
  60. Paulino PJ, Cuthrell KM, Tzenios N. Non Alcoholic Fatty Liver Disease; Disease Burden, Management, and Future Perspectives. International Research Journal of Gastroenterology and Hepatology. 2024 Jan 4;7(1):1-3.
  61. LaBarre C, Bradizza CM, Linn BK, Zhao J, Knapp KS, Wilding GE, Stasiewicz PR. Predictors of National Institute on Alcohol Abuse and Alcoholism (NIAAA) alcohol recovery among individuals in alcohol treatment: Implications for social work. Social Work Research. 2024 Sep;48(3):201-11. https://doi.org/10.1093/swr/svae012 
  62. Epel ES, Crosswell AD, Mayer SE, Prather AA, Slavich GM, Puterman E, Mendes WB. More than a feeling: A unified view of stress measurement for population science. Frontiers in neuroendocrinology. 2018 Apr 1;49:146-69. https://doi.org/10.1016/j.yfrne.2018.03.001 
  63. Watson D. Intraindividual and interindividual analyses of positive and negative affect: their relation to health complaints, perceived stress, and daily activities. Journal of personality and social psychology. 1988 Jun;54(6):1020. https://doi.org/10.1037//0022-3514.54.6.1020 
  64. Attar ET. Review of electroencephalography signals approaches for mental stress assessment. Neurosciences Journal. 2022 Oct 1;27(4):209-15. https://doi.org/10.17712/nsj.2022.4.20220025 
  65. Electrophysiology TF. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 1996 Mar 1;93(5):1043-65. https://doi.org/10.1161/01.CIR.93.5.1043 
  66. Sharafeddin SF, Chehade Z, Sayed SE, Salloum D, Nahouli L, Hannoun A, Ghazeeri G. The effect of environmental stressors on anti-mullerian hormone levels in Lebanese women: a retrospective study. PLoS One. 2025 Nov 6;20(11):e0336016. https://doi.org/10.1371/journal.pone.0336016 
  67. Fonseca-Rodrigues D, Rodrigues A, Martins T, Pinto J, Amorim D, Almeida A, Pinto-Ribeiro F. Correlation between pain severity and levels of anxiety and depression in osteoarthritis patients: a systematic review and meta-analysis. Rheumatology. 2022 Jan 1;61(1):53-75. https://doi.org/10.1093/rheumatology/keab512 
  68. Lyu D, Qian R, Ge F, Wang Y, Wang H, Zhao Y, Han H, Liu R, Liu Y, Chen Y, Ji C. Exploring the associations between data-driven insomnia disorder combined with mild anxiety or/and depressive symptoms and the efficacy of Cognitive-Behavioral Therapy for insomnia. International Journal of Clinical and Health Psychology. 2025 Jan 1;25(1):100562. https://doi.org/10.1016/j.ijchp.2025.100562 
  69. Hüfner K, Rausch LK, Bichler CS, Burtscher J, Falla M, Weiss EM. The effect of aging at moderate altitude on cognition and symptoms of depression and anxiety. Gerontology. 2025 Oct 15;71(10):852-60. https://doi.org/10.1159/000547599 
  70. Miqdadi AI, Chan CM, Alhadidi M, Yoong TL, Hui KO. Assessing the level of panic symptoms, anxiety, and quality of life among people experiencing panic attacks. Journal of Psychosocial Nursing and Mental Health Services. 2025 Jun 1;63(6):39-48. https://doi.org/10.3928/02793695-20250217-05 
  71. AbuNaba'a Y, Basheti IA. Assessing the impact of medication management review service for females diagnosed with depression and anxiety: A randomized control trial. Journal of Evaluation in Clinical Practice. 2020 Oct;26(5):1478-89. https://doi.org/10.1111/jep.13314 
  72. Das KP, Gavade P. A review on the efficacy of artificial intelligence for managing anxiety disorders. Frontiers in Artificial Intelligence. 2024 Oct 16;7:1435895. https://doi.org/10.3389/frai.2024.1435895 
  73. Houglum JE, Harrelson GL, Seefeldt TM. Drugs for treating psychiatric disorders. In Principles of pharmacology for athletic trainers 2024 Jun 1 (pp. 236-267). Routledge.
  74.  Hendriks GJ, Janssen N, Robertson L, van Balkom AJ, van Zelst WH, Wolfe S, Oude Voshaar RC, Uphoff E. Cognitive behavioural therapy and third‐wave approaches for anxiety and related disorders in older people. Cochrane Database of Systematic Reviews. 2024(7). https://doi.org/10.1002/14651858.CD007674.pub3 
  75. Zhu Y, Jha SC, Shutta KH, Huang T, Balasubramanian R, Clish CB, Hankinson SE, Kubzansky LD. Psychological distress and metabolomic markers: A Systematic Review. MedRxiv. 2022 Feb 25:2022-02. https://doi.org/10.1101/2022.02.24.22271464 
  76. Sheffield Z, Paul P, Krishnakumar S, Pan D. Current strategies and future directions of wearable biosensors for measuring stress biochemical markers for neuropsychiatric applications. Advanced Science. 2025 Feb;12(5):2411339. https://doi.org/10.1002/advs.202411339 
  77. Kelaiditis CF, Gibson EL, Dyall SC. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2023 May 1;192:102572. https://doi.org/10.1016/j.plefa.2023.102572

 

 


Converted to clean HTML by WordToHTML.net


Parse error: syntax error, unexpected string content "5d95230bc235864415f2a2323444ee...", expecting ")" in /home/jddtonline/domains/jddtonline.info/public_html/cache/fc-geoIP-all.php on line 26936